DSGN vs J · $214.0M cap vs P/E 36, $14.40B cap
Design Therapeutics Inc (DSGN) versus Jacobs Solutions Inc. (J) — a side-by-side from cached financials, not a winner call.
Design Therapeutics Inc (DSGN) is a biotechnology company listed on US.
Jacobs Solutions Inc. (J) is a engineering & construction company listed on US.
Latest reported DSGN revenue for 2025-09-30 was $0. Net income was -$53.8M. DSGN currently screens at market cap $214.0M.
J does not have a complete income-statement cache yet.
DSGN currently screens at market cap $214.0M. J currently screens at market cap $14.40B and trailing P/E 36.0.
Not investment advice. Open the DSGN and J stock pages for the full models.
Not investment advice.